Simplify Heparin Monitoring with the INNOVANCE Heparin Assay

Improve patient outcomes when monitoring unfractionated heparin with the anti-Xa heparin assay

Improve hospital workflow and make monitoring of unfractionated heparin dosing easier for your staff with the new INNOVANCE® Heparin assay.

With this assay, only one hybrid reference curve is required for measurement of both unfractionated heparin and low molecular weight heparin. Now, heparin samples can be tested immediately, without having to verify which type of heparin the patient is receiving. Labs can run fewer heparin assays - lowering costs of materials, and saving time for clinical staff by enabling them to more quickly deliver heparin test results.

Complete the form below to read a white paper on increasing safety and efficiency in heparin therapy management.

An issue occurred on this form. Either, one or more missing and/or incorrect entries are in the form. Each is underlined in red. Or, the data inserted by you seems to be invalid. Please check if you filled in all form fields as expected according to the field names (e.g. ‘First Name’, ‘Last Name’ etc.). Please correct and re-submit your request again. Thank you!

An issue occurred on this form. The data inserted by you seems to be invalid. Please check if you filled in all form fields as expected according to the field names (e.g. ‘First Name’, ‘Last Name’ etc.). Please correct and re-submit your request again. Thank you!

* Required

Thank you for your interest in Siemens Healthineers.

 

To access your download, please click on the title below:

 > Increasing Safety and Efficiency in Heparin Therapy Management

 

Due to technical reasons your request cannot be completed. Please try again or contact us. We apologize for the inconvenience caused.